Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mats Ehinger

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Blood|December 25, 2009
The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)Christian H Geisler, Arne Kolstad, Anna Laurell, et al.
Plos One|September 1, 2016
A 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic MyelofibrosisVibe Skov, Mark Burton, Mads Thomassen, et al.
Leukemia|July 7, 2026
Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histologyJonas Lippl, Sarah Reinke, Karoline Koch, et al.
Blood Advances|July 28, 2023
Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticityMaria Rodriguez-Zabala, Ramprasad Ramakrishnan, Katrin Reinbach, et al.
Acta Cytologica|May 27, 2020
A Proposal for the Performance, Classification, and Reporting of Lymph Node Fine-Needle Aspiration Cytopathology: The Sydney SystemMousa A Al-Abbadi, Helena Barroca, Beata Bode-Lesniewska, et al.
Blood|November 18, 2020
Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemiaJenny Klintman, Niamh Appleby, Basile Stamatopoulos, et al.
British Journal of Haematology|May 30, 2012
Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occurChristian H Geisler, Arne Kolstad, Anna Laurell, et al.
Blood|March 5, 2015
miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticatorSimon Husby, Ulrik Ralfkiaer, Christian Garde, et al.
Acta Cytologica|August 28, 2025
The World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology - Part 1: Lymph nodeImmacolata Cozzolino, Mats Ehinger, Maria Calaminici, et al.
Acta Cytologica|October 14, 2025
The World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology: Part 2 - Spleen and ThymusImmacolata Cozzolino, Mariarita Calaminici, Andrea Ronchi, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Blood|December 25, 2009
The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)Christian H Geisler, Arne Kolstad, Anna Laurell, et al.
Plos One|September 1, 2016
A 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic MyelofibrosisVibe Skov, Mark Burton, Mads Thomassen, et al.
Leukemia|July 7, 2026
Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histologyJonas Lippl, Sarah Reinke, Karoline Koch, et al.
Blood Advances|July 28, 2023
Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticityMaria Rodriguez-Zabala, Ramprasad Ramakrishnan, Katrin Reinbach, et al.
Acta Cytologica|May 27, 2020
A Proposal for the Performance, Classification, and Reporting of Lymph Node Fine-Needle Aspiration Cytopathology: The Sydney SystemMousa A Al-Abbadi, Helena Barroca, Beata Bode-Lesniewska, et al.
Blood|November 18, 2020
Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemiaJenny Klintman, Niamh Appleby, Basile Stamatopoulos, et al.
British Journal of Haematology|May 30, 2012
Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occurChristian H Geisler, Arne Kolstad, Anna Laurell, et al.
Blood|March 5, 2015
miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticatorSimon Husby, Ulrik Ralfkiaer, Christian Garde, et al.
Acta Cytologica|August 28, 2025
The World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology - Part 1: Lymph nodeImmacolata Cozzolino, Mats Ehinger, Maria Calaminici, et al.
Acta Cytologica|October 14, 2025
The World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology: Part 2 - Spleen and ThymusImmacolata Cozzolino, Mariarita Calaminici, Andrea Ronchi, et al.
Pageof 8